Because we found no difference in CSF or plasma apoE levels between AD patients and nondemented individuals we speculated that the peripheral apoE deficiency observed in APOE ε4 carriers may predispose these individuals to, rather than cause, neurodegenerative disease. The gene discussed is APOE; the disease is Alzheimer disease.